Expression of PD-L1 by the tumor is important not only because it ensures, at the most basic level, that targetable PD-1 receptor–ligand interactions exist in the tumor microenvironment but also because PD-L1 expression correlates with parameters associated with immune activation in the tumor, including activated CD8+T-cell responses and antigen presentation [78]. Here, CD8A is linked to neoplasm.